Tumor-infiltrating CD8+ T cell antitumor efficacy and exhaustion: molecular insights

被引：40
作者：
Kumar, Sandeep [1 ]
Singh, Sunil Kumar [1 ]
Rana, Basabi [1 ,2 ,3 ]
Rana, Ajay [1 ,2 ,3 ]
机构：
[1] Univ Illinois, Div Surg Oncol, Dept Surg, Chicago, IL 60612 USA
[2] Univ Illinois, Univ Illinois Hosp & Hlth Sci Syst Canc Ctr, Chicago, IL 60612 USA
[3] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA
来源：
DRUG DISCOVERY TODAY | 2021年 / 26卷 / 04期
关键词：
INTRATUMORAL IMMUNOTHERAPY; LYMPHOCYTE THERAPY; PHOSPHORYLATED ERK; PD-1; BLOCKADE; LUNG-CANCER; CHECKPOINT; MELANOMA; IMMUNITY; ANTIGEN; AGONIST;
D O I：
10.1016/j.drudis.2021.01.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Host immunity has an essential role in the clinical management of cancers. Therefore, it is advantageous to choose therapies that can promote tumor cell death and concurrently boost host immunity. The dynamic tumor microenvironment (TME) determines whether an antineoplastic drug will elicit favorable or disparaging immune responses from tumor-infiltrating lymphocytes (TILs). CD8+ T cells are one of the primary tumor-infiltrating immune cells that deliver antitumor responses. Here, we review the influence of various factors in the TME on CD8+ T cell exhaustion and survival, and possible strategies for restoring CD8+ T cell effector function through immunotherapy.
引用
收藏
页码：951 / 967
页数：17
相关论文
共 208 条
  • [21] Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint
    Chen, Jiang
    Ji, Tong
    Zhao, Jie
    Li, Gaofeng
    Zhang, Jian
    Jin, Renan
    Liu, Jinghua
    Liu, Xiaolong
    Liang, Xiao
    Huang, Diyu
    Xie, Anyong
    Lin, Hui
    Cang, Yong
    Cai, Xiujun
    [J]. ONCOTARGET, 2016, 7 (27) : 41274 - 41284
  • [22] Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells
    Chen, Qian
    Hu, Quanyin
    Dukhovlinova, Elena
    Chen, Guojun
    Ahn, Sarah
    Wang, Chao
    Ogunnaike, Edikan A.
    Ligler, Frances S.
    Dotti, Gianpietro
    Gu, Zhen
    [J]. ADVANCED MATERIALS, 2019, 31 (23)
  • [23] Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
    Chheda, Zinal S.
    Kohanbash, Gary
    Okada, Kaori
    Jahan, Naznin
    Sidney, John
    Pecoraro, Matteo
    Yang, Xinbo
    Carrera, Diego A.
    Downey, Kira M.
    Shrivastav, Shruti
    Liu, Shuming
    Lin, Yi
    Lagisetti, Chetana
    Chuntova, Pavlina
    Watchmaker, Payal B.
    Mueller, Sabine
    Pollack, Ian F.
    Rajalingam, Raja
    Carcaboso, Angel M.
    Mann, Matthias
    Sette, Alessandro
    Garcia, K. Christopher
    Hou, Yafei
    Okada, Hideho
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 215 (01) : 141 - 157
  • [24] Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
    Chin, S. Michael
    Kimberlin, Christopher R.
    Roe-Zurz, Zygy
    Zhang, Pamela
    Xu, Allison
    Liao-Chan, Sindy
    Sen, Debasish
    Nager, Andrew R.
    Oakdale, Nicole Schirle
    Brown, Colleen
    Wang, Feng
    Yang, Yuting
    Lindquist, Kevin
    Yeung, Yik Andy
    Salek-Ardakani, Shahram
    Chaparro-Riggers, Javier
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [25] STING signaling is a potential immunotherapeutic target in colorectal cancer
    ChonL, Hong Jae
    Kim, Hyojoong
    Noh, Jung Hyun
    Yang, Hannah
    Lee, Won Suk
    Kong, So Jung
    Lee, Seung Jun
    Lee, Yu Seong
    Kim, Woo Ram
    Kim, Joo Hang
    Kim, Gwangil
    Kim, Chan
    [J]. JOURNAL OF CANCER, 2019, 10 (20): : 4932 - 4938
  • [26] Long-term functionality of TCR-transduced T cells in vivo
    Coccoris, Miriam
    Swart, Erwin
    de Witte, Moniek A.
    van Heijst, Jeroen W. J.
    Haanen, John B. A. G.
    Schepers, Koen
    Schumacher, Ton N. M.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (10) : 6536 - 6543
  • [27] Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8+ T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells
    Coelho-dos-Reis, Jordana G.
    Huang, Jing
    Tsao, Tiffany
    Pereira, Felipe V.
    Funakoshi, Ryota
    Nakajima, Hiroko
    Sugiyama, Haruo
    Tsuji, Moriya
    [J]. CLINICAL IMMUNOLOGY, 2016, 168 : 6 - 15
  • [28] A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
    Compte, Marta
    Lykke Harwood, Seandean
    Munoz, Ines G.
    Navarro, Rocio
    Zonca, Manuela
    Perez-Chacon, Gema
    Erce-Llamazares, Ainhoa
    Merino, Nekane
    Tapia-Galisteo, Antonio
    Cuesta, Angel M.
    Mikkelsen, Kasper
    Caleiras, Eduardo
    Nunez-Prado, Natalia
    Aznar, M. Angela
    Lykkemark, Simon
    Martinez-Torrecuadrada, Jorge
    Melero, Ignacio
    Blanco, Francisco J.
    Bernardino de la Serna, Jorge
    Zapata, Juan M.
    Sanz, Laura
    Alvarez-Vallina, Luis
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [29] The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin
    Corgnac, Stephanie
    Boutet, Marie
    Kfoury, Maria
    Naltet, Charles
    Mami-Chouaib, Fathia
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [30] Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
    Dafni, U.
    Michielin, O.
    Lluesma, S. Martin
    Tsourti, Z.
    Polydoropoulou, V.
    Karlis, D.
    Besser, M. J.
    Haanen, J.
    Svane, I. -M.
    Ohashi, P. S.
    Kammula, U. S.
    Orcurto, A.
    Zimmermann, S.
    Trueb, L.
    Klebanoff, C. A.
    Lotze, M. T.
    Kandalaft, L. E.
    Coukos, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (12) : 1902 - 1913
12345678910